Top

Graefe's Archive for Clinical and Experimental Ophthalmology

Published in:

01-05-2013 | Oculoplastics and Orbit

Prognostic factors for outcome of endoscopic dacryocystorhinostomy in patients with primary acquired nasolacrimal duct obstruction

Authors: Shiu Ting Mak, Ida Yu-fong Io, Albert Chak-ming Wong

Published in: Graefe's Archive for Clinical and Experimental Ophthalmology | Issue 5/2013

Abstract

Purpose

To evaluate the prognostic factors for outcome of endoscopic dacryocystorhinostomy (DCR) in patients with primary acquired nasolacrimal duct obstruction.

Materials and Methods

Eighty-three consecutive cases of endoscopic DCR performed for primary acquired nasolacrimal duct obstruction by a single surgeon were included in a retrospective, noncomparative case series. The outcome was assessed at a minimum of 5 months after surgery, being at least 3 months after removal of stents. Surgical success was defined both subjectively and objectively. Subjective success was defined as absence of epiphora. Objective anatomical success was defined as patency on syringing, and presence of a functioning rhinostomy evaluated using the functional endoscopic dye test. Variables assessed included age at surgery, gender, side, duration of intraoperative mitomycin C application, and duration of stent left in-situ. The prognostic factors for outcome were analyzed by the logistic regression test.

Results

Of the 79 analyzed cases, 74 (93.7 %) had successful surgical outcomes. The mean age at time of surgery was 55.5 ± 13.3 years, and the majority of patients were female (85 %). The mean follow-up period was 23.3 ± 16.8 months. Age at surgery is a significant factor influencing the surgical outcome (P < 0.05). Gender, side, duration of intraoperative mitomycin C application, and duration of stent left in-situ had no significant association with the outcome (P > 0.05).

Conclusion

In endoscopic DCR for primary acquired nasolacrimal duct obstruction, younger patient age at time of surgery was associated with a higher rate of failure.

Patel BCK (2009) Management of acquired nasolacrimal duct obstruction: external and endonasal dacryocystorhinostomy. Is there a third way? Br J Ophthalmol 93:1416–1419PubMedCrossRef

Wormald PJ (2002) Powered endoscopic dacryocystorhinostomy. Laryngoscope 112:69–72PubMedCrossRef

Tsirbas A, Wormald PJ (2003) Endonasal dacryocystorhinostomy with mucosal flaps. Am J Ophthalmol 135:76–83PubMedCrossRef

Tsirbas A, Davis G, Wormald PJ (2004) Mechanical endonasal dacryocystorhinostomy versus external dacryocystorhinostomy. Ophthal Plast Reconstr Surg 20:50–56PubMedCrossRef

Yuen KS, Lam LY, Tse MW, Chan DD, Wong BW, Chan WM (2004) Modified endoscopic dacryocystorhinostomy with posterior lacrimal sac flap for nasolacrimal duct obstruction. Hong Kong Med J 10:394–400PubMed

Mahendran S, Stevens-King A, Yung MW (2006) How we do it: the viability of free mucosal grafts on exposed bone in lacrimal surgery — a prospective study. Clin Otolaryngol 31:324–327PubMedCrossRef

Mann BS, Wormald PJ (2006) Endoscopic assessment of the dacryocystorhinostomy ostium after endoscopic surgery. Laryngoscope 116:1172–1174PubMedCrossRef

Sonkhya N, Mishra P (2009) Endoscopic transnasal dacryocystorhinostomy with nasal mucosal and posterior lacrimal sac flap. J Laryngol Otol 123:320–326PubMedCrossRef

Trimarchi M, Giordano Resti A, Bellini C, Forti M, Bussi M (2009) Anastomosis of nasal mucosal and lacrimal sac flaps in endoscopic dacryocystorhinostomy. Eur Arch Otorhinolaryngol 266:1747–1752PubMedCrossRef

10.

Apaydin KC, Fisenk F, Karayalcin B, Akar Y, Saka O (2004) Endoscopic transnasal dacryocystorhinostomy and bicanalicular silicone tube intubation. Ophthalmologica 218:306–311PubMedCrossRef

11.

Tabatabaie SZ, Heirati A, Rajabi MT, Kasaee A (2007) Silicone intubation with intraoperative mitomycin C for nasolacrimal duct obstruction in adults: a prospective, randomized, double-masked study. Ophthal Plast Reconstr Surg 23:455–458PubMedCrossRef

12.

Ugurbas SH, Zilelioglu G, Sargon MF, Anadolu Y, Akiner M, Aktürk T (1997) Histopathologic effects of mitomycin-C on endoscopic transnasal dacryocystorhinostomy. Ophthalmic Surg Lasers 28:300–304PubMed

13.

Zilelioğlu G, Uğurbas SH, Anadolu Y, Akiner M, Aktürk T (1998) Adjunctive use of mitomycin C on endoscopic lacrimal surgery. Br J Ophthalmol 82:63–66PubMedCrossRef

14.

Selig YK, Biesman BS, Rebeiz EE (2000) Topical application of mitomycin-C in endoscopic dacryocystorhinostomy. Am J Rhinol 14:205–207PubMedCrossRef

15.

Deka A, Bhattacharjee K, Bhuyan SK, Barua CK, Bhattacharjee H, Khaund G (2006) Effect of mitomycin C on ostium in dacryocystorhinostomy. Clin Experiment Ophthalmol 34:557–561PubMed

16.

Dolmetsch AM (2010) Nonlaser endoscopic endonasal dacryocystorhinostomy with adjunctive mitomycin C in nasolacrimal duct obstruction in adults. Ophthalmology 117:1037–1040PubMedCrossRef

17.

Ozkiris M, Ozkiris A (2012) Endoscopic dacryocystorhinostomy not using canalicular silicone intubation tube with and without mitomycin C: a comparative study. Eu J Ophthalmol 22:320–325CrossRef

18.

Leong SC, Macewen CJ, White PS (2010) A systematic review of outcomes after dacryocystorhinostomy in adults. Am J Rhinol Allergy 24:81–90PubMedCrossRef

19.

Eyigör H, Unsal AI, Unsal A (2006) The role of accompanying sinonasal abnormalities in the outcome of endonasal dacryocystorhinostomy. Am J Rhinol 20:620–624PubMedCrossRef

20.

Rathore PK, Kumari Sodhi P, Pandey RM (2009) Topical mitomycin C as a postoperative adjunct to endonasal dacryocystorhinostomy in patients with anatomical endonasal variants. Orbit 28:297–302PubMedCrossRef

21.

Zenk J, Karatzanis AD, Psychogios G, Franzke K, Koch M, Hornung J et al (2009) Long-term results of endonasal dacryocystorhinostomy. Eur Arch Otorhinolaryngol 266:1733–1738PubMedCrossRef

22.

Ben Simon GJ, Joseph J, Lee S, Schwarcz RM, McCann JD, Goldberg RA (2005) External versus endoscopic dacryocystorhinostomy for acquired nasolacrimal duct obstruction in a tertiary referral center. Ophthalmology 112:1463–1468PubMedCrossRef

23.

Pittore B, Tan N, Salis G, Brennan PA, Puxeddu R (2010) Endoscopic transnasal dacryocystorhinostomy without stenting: results in 64 consecutive procedures. Acta Otorhinolaryngol Ital 30:294–298PubMed

24.

Hammoudi DS, Tucker NA (2011) Factors associated with outcome of endonasal dacryocystorhinostomy. Ophthal Plast Reconstr Surg 27:266–269PubMedCrossRef

25.

Minasian M, Olver JM (1999) The value of nasal endoscopy after dacryocystorhinostomy. Orbit 18:167–176PubMedCrossRef

26.

Moore WM, Bentley CR, Olver JM (2002) Functional and anatomic results after two types of endoscopic endonasal dacryocystorhinostomy: surgical and holmium laser. Ophthalmology 109:1575–1582PubMedCrossRef

27.

Su CS, Au AW (2011) Endoscopic dacryocystorhinostomy. Ophthalmology 118:793PubMedCrossRef

28.

Konuk O, Kurtulmusoglu M, Knatova Z, Unal M (2010) Unsuccessful lacrimal surgery: causative factors and results of surgical management in a tertiary referral center. Ophthalmologica 224:361–366PubMedCrossRef

29.

Agarwal S (2009) Endoscopic dacryocystorhinostomy for acquired nasolacrimal duct obstruction. J Laryngol Otol 123:1226–1228PubMedCrossRef

30.

Ozer O, Eskiizmir G, Unlü H, Işisağ A, Aslan A (2012) Chronic inflammation: a poor prognostic factor for endoscopic dacryocystorhinostomy. Eur Arch Otorhinolaryngol 269:839–845PubMedCrossRef

31.

Prasannaraj T, Kumar BY, Narasimhan I, Shivaprakash KV (2012) Significance of adjunctive mitomycin C in endoscopic dacryocystorhinostomy. Am J Otolaryngol 33:47–50PubMedCrossRef

32.

Olver JM (2003) The success rates for endonasal dacryocystorhinostomy. Br J Ophthalmol 87:1431PubMedCrossRef

33.

Wong JJ, Metson R, Puliafito CA (1993) Holmium: YAG endonasal dacryocystorhinostomy. Am J Ophthalmol 116:1–10

34.

Kong YT, Kim TI, Kong BW (1994) A report of 131 cases of endoscopic laser lacrimal surgery. Ophthalmology 101:1793–1800PubMed

35.

Boush GA, Lemke BN, Dortzbach RK (1994) Results of endonasal laser-assisted dacryocystorhinostomy. Ophthalmology 101:955–959PubMed

36.

Naraghi M, Tabatabaii Mohammadi SZ, Sontou AF, Farajzadeh Deroee A, Boroojerdi M (2012) Endonasal endoscopic dacryocystorhinostomy: how to achieve optimal results with simple punch technique. Eur Arch Otorhinolaryngol 269:1445–1449PubMedCrossRef

37.

Smirnov G, Pirinen R, Tuomilehto H, Seppä J, Teräsvirta M, Uusitalo H et al (2011) Strong expression of HSP47 in metaplastic nasal mucosa may predict a poor outcome after primary endoscopic dacryocystorhinostomy: a prospective study. Acta Ophthalmol 89:e132–e136PubMedCrossRef

38.

Sato K, Hirano M (1995) Age-related changes of the macula flava of the human vocal fold. Ann Otol Rhinol Laryngol 104:839–844PubMed

39.

Shentu X, Yao K, Sun Z, Yu H, Yang Y (2000) The age-related effect of basic fibroblast growth factor on the proliferation of lens epithelial cells. Zhonghua Yan Ke Za Zhi 36: 341–343,320 [Chinese]

40.

Shentu X, Yao K, Sun C, Xu W, Wu R (2002) Expression and effect of basic fibroblast growth factor on human cataract lens epithelial cells. Chin Med J (Engl) 115:268–271

41.

Ugurbas SH, Zilelioglu G, Sargon MF, Anadolu Y, Akiner M, Akturk T (1997) Histopathologic effects of mitomycin-C on endoscopic transnasal dacryocystorhinostomy. Ophthalmic Surg Lasers 28:300–304PubMed

42.

Camara JG, Bengzon AU, Henson RD (2000) The safety and efficacy of mitomycin C in endonasal endoscopic laser-assisted dacryocystorhinostomy. Ophthal Plast Reconstr Surg 16:114–118PubMedCrossRef

43.

Karkos PD, Leong SC, Sastry A, Assimakopoulos AD, Swift AC (2011) Evidence-based applications of mitomycin C in the nose. Am J Otolaryngol 32:422–425PubMedCrossRef

44.

Dolmetsch AM, Gallon MA, Holds JB (2008) Nonlaser endoscopic endonasal dacryocystorhinostomy with adjunctive mitomycin C in children. Ophthal Plast Reconstr Surg 24:390–393PubMedCrossRef

45.

Penttilä E, Smirnov G, Seppä J, Kaarniranta K, Tuomilehto H (2011) Mitomycin C in revision endoscopic dacryocystorhinostomy: a prospective randomized study. Am J Rhinol Allergy 25:425–428PubMedCrossRef

46.

Ragab SM, Elsherif HS, Shehata EM, Younes A, Gamea AM (2012) Mitomycin C-enhanced revision endoscopic dacryocystorhinostomy: a prospective randomized controlled trial. Otolaryngol Head Neck Surg 147(5):937–942. doi:10.1177/0194599812450280 PubMedCrossRef

47.

Liu D, Bosley TM (2003) Silicone nasolacrimal intubation with mitomycin-C: a prospective, randomized, double-masked study. Ophthalmology 110:306–310PubMedCrossRef

48.

Yildirim C, Yaylali V, Esme A, Ozden S (2007) Long-term results of adjunctive use of mitomycin C in external dacryocystorhinostomy. Int Ophthalmol 27:31–35PubMedCrossRef

49.

Hu D, Sires BS, Tong DC, Royack GA, Oda D (2000) Effect of brief exposure to mitomycin C on cultured human nasal mucosa fibroblasts. Ophthal Plast Reconstr Surg 16:119–125PubMedCrossRef

50.

Muscatello L, Giudice M, Spriano G, Tondini L (2005) Endoscopic dacryocystorhinostomy: personal experience. Acta Otorhinolaryngol Ital 25:209–213PubMed

51.

Gauba V, Islam T, Saleh GM, Zuberbuhler B, Vize C (2008) The practice of dacryocystorhinostomy (DCR) surgery by ophthalmologists in the United Kingdom (UK). Orbit 27:279–283PubMedCrossRef

52.

Gu Z, Cao Z (2010) Silicone intubation and endoscopic dacryocystorhinostomy: a meta-analysis. J Otolaryngol Head Neck Surg 39:710–713PubMed

53.

Feng YF, Cai JQ, Zhang JY, Han XH (2011) A meta-analysis of primary dacryocystorhinostomy with and without silicone intubation. Can J Ophthalmol 46:521–527PubMed

54.

Kim SE, Lee SJ, Lee SY, Yoon JS (2012) Clinical significance of microbial growth on the surfaces of silicone tubes removed from dacryocystorhinostomy patients. Am J Ophthalmol 153:253–257PubMedCrossRef

55.

Vicinanzo MG, McGwin G, Boyle M, Long JA (2008) The consequence of premature silicone stent loss after external dacryocystorhinostomy. Ophthalmology 115:1241–1244PubMedCrossRef

56.

Allen K, Berlin AJ (1989) Dacryocystorhinostomy failure: association with nasolacrimal silicone intubation. Ophthalmic Surg 20:486–489PubMed

57.

Unlu HH, Toprak B, Aslan A, Guler C (2002) Comparison of surgical outcomes in primary endoscopic dacryocystorhinostomy with and without silicone intubation. Ann Otol Rhinol Laryngol 111:704–709PubMed

Title: Prognostic factors for outcome of endoscopic dacryocystorhinostomy in patients with primary acquired nasolacrimal duct obstruction
Authors: Shiu Ting Mak
Ida Yu-fong Io
Albert Chak-ming Wong
Publication date: 01-05-2013
Publisher: Springer-Verlag
Published in: Graefe's Archive for Clinical and Experimental Ophthalmology / Issue 5/2013
Print ISSN: 0721-832X
Electronic ISSN: 1435-702X
DOI: https://doi.org/10.1007/s00417-012-2228-9

At a glance: The STEP trials

Springer Medicine

Prognostic factors for outcome of endoscopic dacryocystorhinostomy in patients with primary acquired nasolacrimal duct obstruction

Abstract

Purpose

Materials and Methods

Results

Conclusion

At a glance: The STEP trials

Springer Medicine

Abstract

Purpose

Materials and Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 5/2013

Graft versus host disease: clinical evaluation, diagnosis and management

Reconstruction of orbital defects by implantation of antigen-free bovine cancellous bone scaffold combined with bone marrow mesenchymal stem cells in rats

Refractive lenticule extraction (ReLEx flex) and wavefront-optimized Femto-LASIK: comparison of contrast sensitivity and high-order aberrations at 1 year

Adherence to ranibizumab treatment for neovascular age-related macular degeneration in real life

Phacoemulsification with perfluorocarbon liquid using a 23-gauge transconjunctival sutureless vitrectomy for the management of dislocated crystalline lenses

Toric implantable collamer lens for moderate to high myopic astigmatism: 3-year follow-up